Cover Image
市場調查報告書

骨水泥:醫療設備的開發平台評估

Bone Cement - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 357841
出版日期 內容資訊 英文 51 Pages
訂單完成後即時交付
價格
Back to Top
骨水泥:醫療設備的開發平台評估 Bone Cement - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年05月09日 內容資訊: 英文 51 Pages
簡介

本報告提供骨水泥相關之開發中產品調查,提供您各開發階段趨勢和產品的主要開發企業,現在進行中的臨床實驗,產業的近幾年趨勢等資訊。

第1章 目錄

第2章 簡介

  • 骨水泥概要

第3章 開發中的產品

  • 骨水泥 - 開發中產品:各開發階段
  • 骨水泥 - 開發中產品:各市場區隔
  • 骨水泥 - 開發中產品:各地區 (國家)
  • 骨水泥 - 開發中產品:各法規途徑
  • 骨水泥 - 開發中產品:各核准時期 (估計)

第4章 骨水泥 - 正在開發的開發中產品:各企業

  • 骨水泥企業 - 開發中產品:各開發階段
  • 骨水泥 - 開發中產品:各開發階段

第5章 骨水泥 開發企業與產品概要

  • aap Implantate AG
  • Biofix Medical Technologies
  • Bone-Rad Therapeutics, Inc.
  • Exactech, Inc.
  • Graftys SAS
  • Meta Biomed Co., Ltd.
  • Onbone Oy
  • Orthox Ltd.
  • Osseon Therapeutics, Inc.
  • Ozics AG
  • Queen's University Belfast
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Synthes, Inc.
  • Teknimed S.A.
  • University of Limerick
  • Zimmer Biomet Holdings, Inc.

第6章 骨水泥 - 近幾年趨勢

第7章 附錄

目錄
Product Code: GDME0184EPD

GlobalData's Medical Devices sector report, "Bone Cement - Medical Devices Pipeline Assessment, 2016" provides an overview of Bone Cement currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bone Cement pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Bone Cement under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Bone Cement and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Bone Cement under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Bone Cement Overview

3. Products under Development

  • 3.1. Bone Cement - Pipeline Products by Stage of Development
  • 3.2. Bone Cement - Pipeline Products by Segment
  • 3.3. Bone Cement - Pipeline Products by Territory
  • 3.4. Bone Cement - Pipeline Products by Regulatory Path
  • 3.5. Bone Cement - Pipeline Products by Estimated Approval Date

4. Bone Cement - Pipeline Products under Development by Companies

  • 4.1. Bone Cement Companies - Pipeline Products by Stage of Development
  • 4.2. Bone Cement - Pipeline Products by Stage of Development

5. Bone Cement Companies and Product Overview

  • 5.1. aap Implantate AG Company Overview
    • 5.1.1. aap Implantate AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Biofix Medical Technologies Company Overview
    • 5.2.1. Biofix Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Bone-Rad Therapeutics, Inc. Company Overview
    • 5.3.1. Bone-Rad Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Exactech, Inc. Company Overview
    • 5.4.1. Exactech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Graftys SAS Company Overview
    • 5.5.1. Graftys SAS Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Meta Biomed Co., Ltd. Company Overview
    • 5.6.1. Meta Biomed Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Onbone Oy Company Overview
    • 5.7.1. Onbone Oy Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Orthox Ltd. Company Overview
    • 5.8.1. Orthox Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Osseon Therapeutics, Inc. Company Overview
    • 5.9.1. Osseon Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Ozics AG Company Overview
    • 5.10.1. Ozics AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Queen's University Belfast Company Overview
    • 5.11.1. Queen's University Belfast Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
    • 5.12.1. Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Synthes, Inc. Company Overview
    • 5.13.1. Synthes, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Teknimed S.A. Company Overview
    • 5.14.1. Teknimed S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. University of Limerick Company Overview
    • 5.15.1. University of Limerick Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Zimmer Biomet Holdings, Inc. Company Overview
    • 5.16.1. Zimmer Biomet Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview

6. Bone Cement- Recent Developments

  • 6.1. Apr 20, 2016: Stryker reports first quarter 2016 results
  • 6.2. Mar 03, 2016: Stryker Raises USD750 Million in Public Offering of 2% Notes Due 2019
  • 6.3. Mar 03, 2016: Stryker Raises USD1 Billion in Public Offering of 4.625% Notes Due 2046
  • 6.4. Mar 03, 2016: Stryker Raises USD1 Billion in Public Offering of 3.5% Notes Due 2026
  • 6.5. Mar 03, 2016: Stryker Raises USD750 Million in Public Offering of 2.625% Notes Due 2021
  • 6.6. Jan 28, 2016: Vexim Raises USD11.3 Million in Private Placement of Shares
  • 6.7. Jan 26, 2016: Stryker Reports 2015 Results and 2016 Outlook
  • 6.8. Jan 26, 2016: Stryker Announces the Retirement of William R. Jellison and the promotion of Glenn S. Boehnlein to Vice President, Chief Financial Officer
  • 6.9. Jan 12, 2016: Stryker Provides 2015 Preliminary Sales Results and Increases Adjusted Earnings Guidance
  • 6.10. Oct 22, 2015: Stryker Reports Third Quarter 2015 Results
  • 6.11. Oct 19, 2015: U.S. Supreme Court To Hear Stryker's Appeal In Zimmer Patent Infringement Suit
  • 6.12. Oct 14, 2015: Ziehm Imaging and Stryker Partner to Provide Surgical Navigation with Ziehm Vision RFD 3D
  • 6.13. Jul 23, 2015: Stryker Reports Second Quarter 2015 Results

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Bone Cement - Pipeline Products by Stage of Development
  • Table 2: Bone Cement - Pipeline Products by Segment
  • Table 3: Bone Cement - Pipeline Products by Territory
  • Table 4: Bone Cement - Pipeline Products by Regulatory Path
  • Table 5: Bone Cement - Pipeline Products by Estimated Approval Date
  • Table 6: Bone Cement Companies - Pipeline Products by Stage of Development
  • Table 7: Bone Cement - Pipeline Products by Stage of Development
  • Table 8: aap Implantate AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Ag Cement - Product Status
  • Table 10: Ag Cement - Product Description
  • Table 11: C-Plug G - Product Status
  • Table 12: C-Plug G - Product Description
  • Table 13: Biofix Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: Injectable Glass Ionomer Cement - Product Status
  • Table 15: Injectable Glass Ionomer Cement - Product Description
  • Table 16: Bone-Rad Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: Spine-Rad Brachytherapy Bone Cement - Product Status
  • Table 18: Spine-Rad Brachytherapy Bone Cement - Product Description
  • Table 19: Exactech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: Bone Cement - Product Status
  • Table 21: Bone Cement - Product Description
  • Table 22: Graftys SAS Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: Phosphocalcic Cement - Product Status
  • Table 24: Phosphocalcic Cement - Product Description
  • Table 25: Meta Biomed Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Bone Cement - Product Status
  • Table 27: Bone Cement - Product Description
  • Table 28: Onbone Oy Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: BIOCEMENT - Product Status
  • Table 30: BIOCEMENT - Product Description
  • Table 31: Orthox Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 32: Fiber-Reinforced Cement - Product Status
  • Table 33: Fiber-Reinforced Cement - Product Description
  • Table 34: Osseon Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: Monetite - Based Injectable Orthopaedic Cement - Product Status
  • Table 36: Monetite - Based Injectable Orthopaedic Cement - Product Description
  • Table 37: Ozics AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: CompO6 Bone Reinforcement Composite - Product Status
  • Table 39: CompO6 Bone Reinforcement Composite - Product Description
  • Table 40: CompO6 Reinforced Bone Composite - Osteoporotic Fractures - Product Status
  • Table 41: CompO6 Reinforced Bone Composite - Osteoporotic Fractures - Product Description
  • Table 42: Queen's University Belfast Pipeline Products & Ongoing Clinical Trials Overview
  • Table 43: Spinal Cement - Product Status
  • Table 44: Spinal Cement - Product Description
  • Table 45: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Bone Cement - Product Status
  • Table 47: Bone Cement - Product Description
  • Table 48: Synthes, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: Statin Eluting Bone Cements - Product Status
  • Table 50: Statin Eluting Bone Cements - Product Description
  • Table 51: Teknimed S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 52: Cemfix 1 - Product Status
  • Table 53: Cemfix 1 - Product Description
  • Table 54: Cemfix 3 - Product Status
  • Table 55: Cemfix 3 - Product Description
  • Table 56: University of Limerick Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: Bioactive Adhesive Cement - Product Status
  • Table 58: Bioactive Adhesive Cement - Product Description
  • Table 59: Dual Calcium Phosphate Paste System - Product Status
  • Table 60: Dual Calcium Phosphate Paste System - Product Description
  • Table 61: Heracap - Product Status
  • Table 62: Heracap - Product Description
  • Table 63: Zimmer Biomet Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 64: Cobalt Stage One Acrylic Spacer Cement - Product Status
  • Table 65: Cobalt Stage One Acrylic Spacer Cement - Product Description
  • Table 66: Glossary

List of Figures

  • Figure 1: Bone Cement - Pipeline Products by Stage of Development
  • Figure 2: Bone Cement - Pipeline Products by Segment
  • Figure 3: Bone Cement - Pipeline Products by Territory
  • Figure 4: Bone Cement - Pipeline Products by Regulatory Path
  • Figure 5: Bone Cement - Pipeline Products by Estimated Approval Date
Back to Top